miscsubjectsAI governance
Evidence review

PT-141 for Neuropathy: Evidence-Graded Review

· · 3 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `pt-141-neuropathy`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/pt-141-neuropathy

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-neuropathy/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-neuropathy/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-neuropathy/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-neuropathy/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why PT-141 might help you

  1. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • PT-141 → sexual / CNS arousal

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 4

Quantified confidence (this ledger): 0.33 / 1.00 — low — animal and anecdote heavy

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Novel Emerging Therapies for Erectile Dysfunction (source s1)

Reviews PT-141 studies limited to ED endpoints; no neuropathy data.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Salvage of sildenafil failures with bremelanotide (source s2)

Small crossover study of related compound including neuropathy patients but only ED outcomes.

Evidence type: Published research.

Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder (source s3)

Phase 3 HSDD data; no neuropathy cohorts.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

Taken PT-141 twice now and I am happily amazed — Reddit, r/erectiledysfunction (source s4)

User reports focus on sexual effects; no neuropathy mentions.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Neuropathy (general) · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedPT-141: Brain-Level Arousal · 17 humanPT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood… · 8 humanPT-141 for Chemotherapy Side Effects: Evidence on Sexual Arousal Pathw… · 3 humanPT-141 for Diabetic Neuropathy: Evidence-Graded Review · 3 human
Evidence · 4 sources · swipe →chain edfce5464843 · verify chain · provenance
1 / 4
Evidence ledger 4 · tier-ranked · API
human
No human trials examine PT-141 for neuropathy itself.
sources: s1
human
Phase 3 bremelanotide trials demonstrated increased desire scores versus placebo in HSDD.
sources: s3
mechanisticlow confidence
Early MT-II study included men with peripheral neuropathic injury but measured only erectile response.
sources: s2
anecdotallow confidence
Reddit users report stronger erections and arousal but no changes in neuropathic pain or nerve function.
sources: s4
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 01:13
PT-141 for Neuropathy: Evidence-Graded Review · 4 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: PT 141 for Neuropathy
Slug: pt-141-neuropathy
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"pt-141","name":"PT-141"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenerative
it output
{
  "slug": "pt-141-neuropathy",
  "title": "PT-141 for Neuropathy: Evidence-Graded Review",
  "body": "## What's breaking down\n\nNeuropathy involves progressive nerve fiber damage and failed repair. Degeneration outpaces regeneration in peripheral nerves or central pathways. Layers include axonal loss, myelin breakdown, reduced blood flow to nerves, inflammation, and disrupted signaling. In diabetic or peripheral cases, this can affect sensation, pain processing, and autonomic functions such as arousal pathways. Mechanical or metabolic stress accelerates breakdown while repair signals remain weak.\n\n## Why PT-141 might help you\n\nPT-141 acts on melanocortin receptors in the central nervous system to influence arousal circuits.  \n\n1. If your neuropathy overlaps with impaired CNS arousal signaling, PT-141 is discussed for its direct action on those brain pathways rather than local tissue repair.  \n2. If nerve damage has reduced natural arousal responses, the peptide's mechanism targets central initiation of desire and response.  \n3. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain. The focus stays on supporting arousal pathways that neuropathy may have disrupted.\n\n## How these fit together\n\nSingle-compound focus. PT-141 addresses the sexual / CNS arousal layer. No siblings in s
3aca6ffc08a4edf6
Machine verification: /api/articles/pt-141-neuropathy/contributions

Related articles

Neuropathy (general) · condition map

Open evidence map →
PT-141: Brain-Level Arousalpt-141PT-141 and Benzodiazepine Withdrawal: A Data-First Evidence Reviewpt-141-benzo-withdrawalPT-141 and Benzodiazepines: Evidence Review on CNS Arousal Layerspt-141-benzodiazepinesPT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood…pt-141-blood-pressure-medsPT-141 for Statin-Associated Cognitive Effects: Evidence Reviewpt-141-brain-fogPT-141 for Carpal Tunnel Syndrome: A Data-First Evidence Reviewpt-141-carpal-tunnel
Ask this article · 7 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "No human trials examine PT-141 for neuropathy itself."?
ask pt-141-neuropathy claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "Phase 3 bremelanotide trials demonstrated increased desire scores versus placebo in HSDD."?
ask pt-141-neuropathy claim c3 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "Early MT-II study included men with peripheral neuropathic injury but measured only erectile response."?
ask pt-141-neuropathy claim c2 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users report stronger erections and arousal but no changes in neuropathic pain or nerve function."?
ask pt-141-neuropathy claim c4 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User reports focus on sexual effects; no neuropathy mentions."
ask pt-141-neuropathy source s4 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about PT-141 for Neuropathy: Evidence-Graded Review — and what would you need me to tell you first?
ask pt-141-neuropathy condition gaps · paste includes §SELF
What good and bad outcomes are documented for PT-141 for Neuropathy: Evidence-Graded Review (studies vs anecdotes)?
ask pt-141-neuropathy good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…